The U.S. Supreme Court’s decision Monday to put restrictions on where patent lawsuits can be filed will limit the ability of patent owners to file cases in favorable courts, likely marking the end of the Eastern District of Texas as a patent litigation hot spot. Here, Law360 takes a look at the impact and other possible fallout from the ruling.
German footwear and athletic-gear maker Adidas Salomon AG has sued Ralph Lauren Corp. for trademark infringement, accusing the U.S. fashion label’s Polo line of copying its famous three-striped logo.
In a move designed to curb patent evergreening, India’s government is considering legislation that would limit data exclusivity to four years, according to local media reports.
Michigan State University has established a master’s program in intellectual property and communications law, one of less than twenty such programs in the U.S.
Australian biotech company Benitec Ltd. has settled its U.S. patent infringement case against rival Genscript over gene silencing technologies, just two weeks after it settled its suit against Ambion under similar terms.
A federal court has once again dismissed a lawsuit filed by the Promega Corp. against Roche and Applied Biosystems, which alleged that the companies committed fraud against the U.S. government, Roche said.
Medimmune Oncology has sued Indian generic maker Sun Pharmaceuticals over its plans to make a generic version of the cancer-related drug Ethyol (amifostine).
A federal court has scheduled a preliminary hearing for Dec. 8 in Sanofi-Aventis' patent infringement lawsuit against Apotex and Dr. Reddy’s over its blood-thinning drug Plavix, following months of delays.
Taiwanese chip makers MStar Semiconductor, Media Reality Technologies (MRT) and Trumpion Microelectronics infringed a patent for liquid crystal display (LCD) controllers held by rival Genesis Microchip, the U.S. International Trade Commission said in a final determination.
A federal court has denied drug maker Pfizer Inc.’s attempt to bar Ivax Corp. from introducing a generic version of blockbuster epilepsy drug Neurontin.
Gary Abelev has left Baker & Botts to join Dorsey & Whitney as a partner in the firm’s intellectual property group in New York City.
A federal judge has upheld the validity of two key method-of-use patents for GlaxoSmithKline’s anti-nausea drug Zofran (ondansetron), dealing a blow to challenger Teva Pharmaceuticals.
A former employee of Pfizer Japan Inc. has filed a lawsuit against the U.S. drug maker with the Tokyo District Court, seeking 1 billion yen for what he claims is his invention of a technology for dosage adjustments.
Biotech rivals Illumina, Inc. and Applera Corp. have agreed to settle two lawsuits over a partnership that went sour, penning a deal that involves royalty-free cross-licensing of key technologies and the dismissal of a patent infringement suit.
In a major setback for the entertainment industry, a federal appeals court in California has ruled that online file-sharing software companies are not liable for copyright infringement.
Taiwan Semiconductor has filed an unfair import complaint with the U.S. International Trade Commission (ITC), seeking a probe of a mainland rival already targeted in a trade-secret lawsuit in California.
A federal judge has denied ZonePerfect Nutrition Company's request for a preliminary injunction to stop the sale of Hershey Foods Corporation’s SmartZone nutrition bar.
A federal judge has ruled that the U.S. Food and Drug Administration (FDA) acted appropriately in withdrawing its final approval of Mylan Laboratories's Abbreviated New Drug Application (ANDA) for its generic version of Alza Corp.’s Duragesic, a painkiller delivered to the skin through a patch.
The U.S. Patent and Trademark Office has rejected all 10 claims under review in its reexamination of the controversial “Eolas” browser patent at the center of a $565 million patent infringement judgment against Microsoft, according to a published report.
Software maker Compuware has filed an emergency motion in its copyright and trade-secret lawsuit against IBM, accusing Big Blue of failing to introduce crucial evidence until after the close of the case's discovery period.
The U.S. Court of Appeals for the Federal Circuit has affirmed a district court jury's finding that Dorel Industries’ Safety 1st unit infringed two patents held by toymaker Mattel Inc.’s Fisher-Price unit, and said another product should be considered when a new jury calculates damages.